The journey towards implementation of the NHS Diabetes Prevention Programme: A personal perspective

Jonathan Valabhji^{1

2

3}

Affiliations

¹ Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
² Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
³ NHS England, London, UK.

Editorial

Jonathan Valabhji. Diabet Med. 2023 Nov.

. 2023 Nov;40(11):e15238.

doi: 10.1111/dme.15238.

Jonathan Valabhji^{1

2

3}

¹ Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
² Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
³ NHS England, London, UK.

No abstract available

References

1. Bower P, Soiland-Reyes C, Heller S, et al. Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England. Diabet Med. 2023;40(11):e15209. doi:10.1111/dme.15209
1. NHS England. Five Year Forward View. Accessed October 8, 2023. https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf
1. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care. 1997;20(4):537-544. doi:10.2337/diacare.20.4.537
1. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350. doi:10.1056/NEJM200105033441801
1. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. doi:10.1056/NEJMoa012512